Barclays analyst Adrienne Yih raised the firm’s price target on Bath & Body Works to $32 from $30 and keeps an Equal Weight rating on the shares following the fiscal Q2 report. The firm says Bath & Body’s tariff impacts will be largest in Q3, as inventory flows-through.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BBWI:
- Bath & Body Works Reports Strong Q2 2025 Results
- Bath & Body Works: Buy Rating Affirmed Amid Strategic Growth Potential and Overcoming Challenges
- Nvidia reports Q2 beat, Snowflake posts ‘beat and raise’: Morning Buzz
- Morning Movers: Burlington and Victoria’s Secret higher after quarterly results
- Bath & Body Works sees Q3 EPS 37c-45c, consensus 49c